Association Between Impella Device Support and Elevated Rates of Gout Flares: A Retrospective Analysis
Abstract Background Impella is an advanced ventricular assist device frequently used as a bridge to heart transplantation. The association of Impella with increased rates of gout flares has not been studied. Our primary aim is to determine the rates of gout flares in patients on Impella support. Methodology A retrospective study was conducted between January 2017 and September 2022 involving all patients who underwent heart transplantation. The cohort was divided into groups based on Impella support for statistical analysis. In patients receiving Impella support, outcome measures were compared based on the development of gout flares. Results 213 patients were analyzed, with 19.71% supported by Impella. Impella and non-Impella groups had similar age, race, and BMI, but more males were in the Impella group. Gout and chronic kidney disease were more prevalent in Impella-supported patients, while coronary artery disease was less common. The incidence of gout flare was significantly higher in Impella patients (31% vs. 5.3%). The Impella group had an adjusted odds ratio for in-hospital gout flare of 8.069 (95% CI = 2.13–35.08, P = 0.003). Impella-supported patients with gout flares had longer intensive care unit and hospital stays but no difference in mortality or other outcomes. Conclusion Our study is the first to identify the potential association between Impella support and increased rates of gout flares in hospitalized patients. Future studies are required to confirm this association and further elucidate the biological pathways. It is imperative to consider introducing appropriate measures to prevent and promptly manage gout flares in Impella-supported patients..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
ResearchSquare.com - (2023) vom: 13. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sinclair, Jorge [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.21203/rs.3.rs-3549951/v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XRA041528859 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | XRA041528859 | ||
| 003 | DE-627 | ||
| 005 | 20231114130657.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231114s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21203/rs.3.rs-3549951/v1 |2 doi | |
| 035 | |a (DE-627)XRA041528859 | ||
| 035 | |a (ResearchSquare)10.21203/rs.3.rs-3549951/v1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sinclair, Jorge |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Association Between Impella Device Support and Elevated Rates of Gout Flares: A Retrospective Analysis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Impella is an advanced ventricular assist device frequently used as a bridge to heart transplantation. The association of Impella with increased rates of gout flares has not been studied. Our primary aim is to determine the rates of gout flares in patients on Impella support. Methodology A retrospective study was conducted between January 2017 and September 2022 involving all patients who underwent heart transplantation. The cohort was divided into groups based on Impella support for statistical analysis. In patients receiving Impella support, outcome measures were compared based on the development of gout flares. Results 213 patients were analyzed, with 19.71% supported by Impella. Impella and non-Impella groups had similar age, race, and BMI, but more males were in the Impella group. Gout and chronic kidney disease were more prevalent in Impella-supported patients, while coronary artery disease was less common. The incidence of gout flare was significantly higher in Impella patients (31% vs. 5.3%). The Impella group had an adjusted odds ratio for in-hospital gout flare of 8.069 (95% CI = 2.13–35.08, P = 0.003). Impella-supported patients with gout flares had longer intensive care unit and hospital stays but no difference in mortality or other outcomes. Conclusion Our study is the first to identify the potential association between Impella support and increased rates of gout flares in hospitalized patients. Future studies are required to confirm this association and further elucidate the biological pathways. It is imperative to consider introducing appropriate measures to prevent and promptly manage gout flares in Impella-supported patients. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Isha, Shahin |4 aut | |
| 700 | 1 | |a Olivero, Lorenzo |4 aut | |
| 700 | 1 | |a Raavi, Lekhya |4 aut | |
| 700 | 1 | |a Narra, Sai Abhishek |4 aut | |
| 700 | 1 | |a Paghdar, Smit |4 aut | |
| 700 | 1 | |a Jonna, Sadhana |4 aut | |
| 700 | 1 | |a Satashia, Parthkumar |4 aut | |
| 700 | 1 | |a Hannon, Rachel |4 aut | |
| 700 | 1 | |a Blasavage, Jessica |4 aut | |
| 700 | 1 | |a White, Layton |4 aut | |
| 700 | 1 | |a Olanipekun, Titilope |4 aut | |
| 700 | 1 | |a Bansal, Pankaj |4 aut | |
| 700 | 1 | |a Kiley, Sean |4 aut | |
| 700 | 1 | |a Leoni, Juan Carlos |4 aut | |
| 700 | 1 | |a Nativí, Jose N. |4 aut | |
| 700 | 1 | |a Lyle, Melissa |4 aut | |
| 700 | 1 | |a Thomas, Mathew |4 aut | |
| 700 | 1 | |a Sareyyupoglu, Basar |4 aut | |
| 700 | 1 | |a Pham, Si |4 aut | |
| 700 | 1 | |a Smith, Michael |4 aut | |
| 700 | 1 | |a Franco, Pablo Moreno |4 aut | |
| 700 | 1 | |a Patel, Parag |4 aut | |
| 700 | 1 | |a Sanghavi, Devang |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2023) vom: 13. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:13 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-3549951/v1 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XRA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 13 |c 11 | ||